High Flow Oxygen Therapy and Acute Ischemic Stroke
Primary Purpose
Stroke
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
High flow oxygen
Low flow oxygen
Sponsored by
About this trial
This is an interventional treatment trial for Stroke focused on measuring High flow oxygen therapy, Oxygen desaturation index, Acute ischemic stroke
Eligibility Criteria
Inclusion Criteria:
- Age of 18 or more
- Clinical and radiographic findings including computerized tomography of brain compatible with acute ischemic stroke
- Presentation within 72 hours after the stroke onset
- National of Health Stroke Scale (NIHSS) of 5 or more,
- Limb weakness defined as motor power grade of 4 or less,
- Able to give informed consent, or the next of kin was willing to give assent
Exclusion Criteria:
- Recognized indications for oxygen treatment, such as oxygen saturation on room air of less than 92%, acute left ventricular failure, severe pneumonia, pulmonary emboli, and chronic respiratory failure treated with home oxygen supplementation
- Recognized contraindications for oxygen treatment including chronic hypercapnia and type II respiratory failure
- Subjects with previous diagnosis of obstructive sleep apnea (OSA) or highly suspicious of OSA, screened by STOPBANG score of 5 or more
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
No Intervention
Active Comparator
Experimental
Arm Label
No oxygen
Low flow oxygen
High flow oxygen
Arm Description
No oxygen supplementation given
Oxygen cannula with a flow rate of 2 liter/minute
Heated humidified high flow oxygen cannula (Optiflow; temperature of 34°C and fractional inspired oxygen of 0.24) with a flow rate of 20 liter/minute
Outcomes
Primary Outcome Measures
Oxygen desaturation index
The number of times per hour that the oxygen saturation measured by pulse oximetry drop from baseline more than 4% for at least 10 seconds
Secondary Outcome Measures
Mean oxygen saturation
Lowest oxygen saturation
The number of subjects with oxygen desaturation
Percentages of cumulative time of oxygen desaturation
NIHSS changes
The NIHSS at randomization minus the NIHSS at the 7th day of admission
The number of subjects with NIHSS improvement by 4 or more
Full Information
NCT ID
NCT03402594
First Posted
January 11, 2018
Last Updated
January 11, 2018
Sponsor
Chulalongkorn University
1. Study Identification
Unique Protocol Identification Number
NCT03402594
Brief Title
High Flow Oxygen Therapy and Acute Ischemic Stroke
Official Title
Effects of High Flow Oxygen Therapy on Oxygen Desaturation Index in Patients With Acute Ischemic Stroke
Study Type
Interventional
2. Study Status
Record Verification Date
November 2017
Overall Recruitment Status
Completed
Study Start Date
July 1, 2016 (Actual)
Primary Completion Date
March 31, 2017 (Actual)
Study Completion Date
June 30, 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Chulalongkorn University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Hypoxemia is common in acute ischemic stroke and associated with neurological deterioration and mortality. However, the benefit of oxygen therapy is controversial. Severity of stroke may affect the benefit of oxygen supplementation. Abnormal breathing patterns are commonly found among stroke patients and may increase the risk of hypoxemia. High flow nasal cannula (HFNC) has several advantages from controllable fraction of inspired oxygen (FiO2), reduction of nasopharyngeal resistance and positive end expiratory pressure effect. In this study, we aimed to assess the therapeutic effect of HFNC on oxygen desaturation index (ODI) and neurological outcomes in stroke patients with moderate and severe severities, compared with no and low flow oxygen supplementation.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stroke
Keywords
High flow oxygen therapy, Oxygen desaturation index, Acute ischemic stroke
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
30 (Actual)
8. Arms, Groups, and Interventions
Arm Title
No oxygen
Arm Type
No Intervention
Arm Description
No oxygen supplementation given
Arm Title
Low flow oxygen
Arm Type
Active Comparator
Arm Description
Oxygen cannula with a flow rate of 2 liter/minute
Arm Title
High flow oxygen
Arm Type
Experimental
Arm Description
Heated humidified high flow oxygen cannula (Optiflow; temperature of 34°C and fractional inspired oxygen of 0.24) with a flow rate of 20 liter/minute
Intervention Type
Device
Intervention Name(s)
High flow oxygen
Intervention Description
Heated humidified high flow oxygen cannula (Optiflow; temperature of 34°C and fractional inspired oxygen of 0.24) with a flow rate of 20 liter/minute
Intervention Type
Device
Intervention Name(s)
Low flow oxygen
Intervention Description
Oxygen cannula with a flow rate of 2 liter/minute
Primary Outcome Measure Information:
Title
Oxygen desaturation index
Description
The number of times per hour that the oxygen saturation measured by pulse oximetry drop from baseline more than 4% for at least 10 seconds
Time Frame
In the first 24 hours of study period
Secondary Outcome Measure Information:
Title
Mean oxygen saturation
Time Frame
In the first 24 hours of study period
Title
Lowest oxygen saturation
Time Frame
In the first 24 hours of study period
Title
The number of subjects with oxygen desaturation
Time Frame
In the first 24 hours of study period
Title
Percentages of cumulative time of oxygen desaturation
Time Frame
In the first 24 hours of study period
Title
NIHSS changes
Description
The NIHSS at randomization minus the NIHSS at the 7th day of admission
Time Frame
at the 7th day of admission or at discharge date
Title
The number of subjects with NIHSS improvement by 4 or more
Time Frame
at the 7th day of admission or at discharge date
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age of 18 or more
Clinical and radiographic findings including computerized tomography of brain compatible with acute ischemic stroke
Presentation within 72 hours after the stroke onset
National of Health Stroke Scale (NIHSS) of 5 or more,
Limb weakness defined as motor power grade of 4 or less,
Able to give informed consent, or the next of kin was willing to give assent
Exclusion Criteria:
Recognized indications for oxygen treatment, such as oxygen saturation on room air of less than 92%, acute left ventricular failure, severe pneumonia, pulmonary emboli, and chronic respiratory failure treated with home oxygen supplementation
Recognized contraindications for oxygen treatment including chronic hypercapnia and type II respiratory failure
Subjects with previous diagnosis of obstructive sleep apnea (OSA) or highly suspicious of OSA, screened by STOPBANG score of 5 or more
12. IPD Sharing Statement
Learn more about this trial
High Flow Oxygen Therapy and Acute Ischemic Stroke
We'll reach out to this number within 24 hrs